Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumor: A Systematic Review

Background: The introduction of tyrosine kinase inhibitor (TKI) therapy has dramatically improved the clinical effectiveness of patients with locally advanced and/or metastatic gastrointestinal stromal tumors (GIST), and this systematic review was conducted aiming at the cost-effectiveness analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Mingyang, Yang, Yang, Liao, Weiting, Li, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784780/
https://www.ncbi.nlm.nih.gov/pubmed/35083189
http://dx.doi.org/10.3389/fpubh.2021.768765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784780/
https://www.ncbi.nlm.nih.gov/pubmed/35083189
http://dx.doi.org/10.3389/fpubh.2021.768765

Ejemplares similares